canonical: https://aviantestpro.com/knowledge/disease-testing/avian-influenza-surveillance
Avian Influenza Surveillance
Testing Overview
SENO provides influenza A virus detection with H5, H7, H9 subtyping by RT-PCR. Testing is available for individual birds or flock-level surveillance programs. Our Zhangjiakou laboratory follows WHO/OIE-recommended protocols for avian influenza detection and subtyping, with validated sensitivity for all avian species.
Avian influenza is a notifiable disease under OIE guidelines. Racing pigeon owners, breeders, and loft managers are increasingly required to provide current AIV-negative certification for competition entry, cross-border movement, and annual registration.
Why AIV Surveillance Matters for Racing Pigeons
| Justification | Detail |
|---|
| Regulatory compliance | Many Chinese provinces require AIV-negative status for racing events |
| Cross-border movement | Hong Kong, Macau, and international races mandate pre-race screening |
| Flock health | Early detection prevents within-loft spread and production losses |
| Zoonotic risk | H5N1 and H7N9 have documented human spillover potential |
| Insurance requirements | Some policies for high-value birds require AIV status confirmation |
Methodology
- Screening: RT-PCR targeting the Influenza A matrix (M) gene
- Subtyping: H5, H7, and H9-specific RT-PCR
- Reporting: M gene Ct + subtype Ct + interpretation
Step-by-Step Laboratory Workflow
| Step | Procedure | Duration | QC Check |
|---|
| 1 | Sample receipt and accessioning | 0.5 h | Verify sample integrity, check documentation |
| 2 | RNA extraction (magnetic bead or column-based) | 1 h | Extraction blank included |
| 3 | M gene RT-PCR screening (duplicate) | 2 h | Positive control Ct within range |
| 4 | If M gene positive → H5, H7, H9 subtyping | 2 h | Subtype-specific controls |
| 5 | Data analysis and interpretation | 0.5 h | Ct thresholds, melt curve (if SYBR) |
| 6 | Report generation and review | 0.5 h | Second-technician verification |
| 7 | Result delivery (email + WeChat) | — | — |
Primer and Probe Details
| Target | Primer / Probe | Amplicon Size | Specificity |
|---|
| Influenza A M gene | WHO-recommended M-F/M-R + M-probe (FAM) | ~100 bp | All Influenza A subtypes |
| H5 hemagglutinin | H5-specific primers + H5-probe (VIC) | ~150 bp | H5 subtypes (H5N1, H5N2, H5N6, H5N8) |
| H7 hemagglutinin | H7-specific primers + H7-probe (CY5) | ~130 bp | H7 subtypes (H7N3, H7N7, H7N9) |
| H9 hemagglutinin | H9-specific primers + H9-probe (ROX) | ~140 bp | H9 subtypes (H9N2 most common) |
| Internal control | IC primers + IC-probe (HEX) | ~80 bp | Exogenous RNA control |
Clinical Relevance
| Subtype | Pathogenicity in Pigeons | Typical Presentation | Zoonotic Risk | Regulatory Concern |
|---|
| H5N1 | Moderate (neurologic) | Ataxia, torticollis, sudden death, egg drop | High | Reportable (OIE) |
| H7N9 | Low (mild respiratory) | Conjunctivitis, mild rales, sinusitis | High | Reportable (OIE) |
| H9N2 | Low (mild respiratory) | Subtle respiratory; often co-infection with Mycoplasma or E. coli | Low-medium | Reportable in some regions |
H5N1 (Highly Pathogenic Avian Influenza)
| Attribute | Detail |
|---|
| Clade | 2.3.4.4b (predominant globally since 2021) |
| Incubation period in pigeons | 2–7 days |
| Mortality rate in pigeons | Variable (up to 40% in experimental infections) |
| Shedding duration | 5–10 days post-infection |
| Diagnostic window | Days 1–10 post-exposure (best sensitivity days 3–7) |
H7N9 (Low Pathogenic → Highly Pathogenic)
| Attribute | Detail |
|---|
| Status | LPAI in poultry, but HPAI strains have emerged in some outbreaks |
| Pigeon susceptibility | Limited replication; rare clinical disease |
| Human case fatality rate | ~39% (WHO data from 2013–2019) |
| Surveillance priority | High due to pandemic potential |
H9N2 (Low Pathogenic)
| Attribute | Detail |
|---|
| Prevalence in pigeons | Moderate; common in live poultry markets |
| Clinical impact | Usually mild; significant synergism with bacterial pathogens |
| Economic effect | Loss of racing performance, reduced egg production |
| Vaccine use | Widespread in Chinese poultry; spillover possible |
Ct Value Interpretation
| M Gene Ct Range | Interpretation | Action |
|---|
| < 30 | Strong positive — high viral load | Immediate isolation, confirm subtype, notify authorities |
| 30–35 | Positive — moderate viral load | Isolate, retest in 48 h, begin subtype testing |
| 35–38 | Weak positive — low viral load | Retest in duplicate; consider pooled vs. individual |
| 38–40 | Borderline | Retest with fresh sample; consider clinical context |
| No Ct or > 40 | Negative | No detectable Influenza A RNA |
Recommended Testing Frequency
| Scenario | Recommendation | Rationale |
|---|
| Racing pigeons — active season (spring/autumn) | Quarterly screening | Peak exposure during transport and congregation |
| Birds entering new loft/facility | Pre-introduction + 2-week quarantine test | Prevents introduction from outside sources |
| Outbreak in neighboring region | Monthly monitoring until risk passes | Early detection before clinical signs appear |
| Annual permit requirement | Once per year (timed pre-season) | Meets regulatory documentation requirements |
| Loft with previous AIV history | Pre-season + mid-season | Higher recurrence risk |
| Mixed-species loft (pigeons + poultry) | Monthly during poultry outbreak season | Cross-species transmission risk |
SENO AIV Surveillance Program
| Program Feature | Detail |
|---|
| Screening method | RT-PCR (M gene + subtype) |
| Minimum sample size (surveillance) | 10% of flock or 10 birds (whichever greater) |
| Maximum sample per submission | 200 samples per batch (larger batches by arrangement) |
| Turnaround | 2–3 working days (screening + subtyping) |
| Pooled testing available | 3 birds per pool for surveillance (not for clinical cases) |
| Report includes | M gene Ct, subtype (if positive), interpretation |
| Archival | Results retained for 3 years for regulatory review |
| Rush processing | Available: results within 24 hours (contact lab) |
Program Levels
| Tier | Scope | Price Tier | Best For |
|---|
| Basic | M gene screening only | Standard | Routine annual checks |
| Standard | M gene + H5/H7/H9 subtyping | Standard + subtype | Pre-race screening, permit requirements |
| Enhanced | Standard + sequenced HA/NA (if positive) | Premium | Outbreak investigation, research |
| Full Surveillance | 4 quarterly screens + report summary | Contract | Lofts with ongoing regulatory requirements |
| Export Certification | Multiple pathogens including AIV | Consultation | International movement of birds |
Sample Requirements
| Sample Type | Quantity | Notes |
|---|
| Oropharyngeal swab | 1 per bird | Preferred for early detection (respiratory tropism) |
| Cloacal swab | 1 per bird | May be positive later; recommended in combination |
| Combined (oro + cloacal) swab | 1 per bird | Best sensitivity — recommended by OIE |
| Feathers | Not recommended for AIV | Low sensitivity compared to swabs |
| Tissue (post-mortem) | 5 × 5 × 5 mm (lung or trachea) | For deceased birds |
Preventing False Negatives
| Factor | Mitigation |
|---|
| Early infection (pre-shedding) | Retest after 48 h if high suspicion |
| Intermittent shedding | Multiple sampling over 5–7 days |
| Sample degradation | Ship with ice packs; use RNA-stabilizing media |
| PCR inhibition | Internal amplification control in every reaction |
| Low viral load | Collect combination swabs (oral + cloacal) |
Regulatory Reporting
If AIV (especially H5 or H7) is detected, SENO will:
| Step | Action |
|---|
| 1 | Immediately notify submitting veterinarian/owner |
| 2 | Repeat test on a fresh aliquot to confirm |
| 3 | Sequence HA gene if requested |
| 4 | Report to local agricultural/animal health authority (as required by law) |
| 5 | Provide documentation for official follow-up |
Frequently Asked Questions
| Question | Answer |
|---|
| Can I race my pigeon while waiting for AIV results? | No — ensure results are received and negative before competition. |
| What if a pooled sample is positive? | We will retest individual birds from the pool to identify carriers. |
| Does AIV vaccination affect test results? | Yes — vaccinated birds may shed lower levels of virus. Testing is still recommended. |
| Is H9N2 a reportable disease? | In some Chinese provinces, yes. Check local regulations. |
| How long is an AIV-negative result valid? | Typically 30 days for competition purposes; check event rules. |
SENO is committed to providing accurate, timely, and trusted molecular diagnostics for the global avian community. For questions about test selection, interpretation, or research collaboration, contact our technical team.